Table 2.
Parameter | Whole study population | <10 years | 10–14 years | >14 years |
---|---|---|---|---|
LDL (mg/dL) | 96.5 (18–190) | 105 (49–183) | 97 (18–190) | 95 (66–151) |
HDL (mg/dL) | 49 (30–111) | 50 (36–79) | 52 (30–111) | 48 (33–77) |
Total cholesterol (mg/dL) | 169 (81–265) | 174 (112–265) | 169 (81–265) | 164 (115–216) |
Triglycerides (mg/dL) | 79.5 (17–379) | 88 (29–200) | 99 (17–379) | 104 (79–241) |
GOT (U/L) | 26 (10–118) | 28 (11–43) | 29 (11–118) | 22 (10–40) |
GPT (U/L) | 38.5 (16–250) | 40 (20–98) | 50 (16–250) | 39 (20–65) |
GGT (U/L) | 18 (6–58) | 17 (6–39) | 20 (10–58) | 22 (10–48) |
Fasting glucose (mg/dL) | 88 (71–318) | 85 (71–101) | 92 (78–264) | 197 (76–318) |
Urea (mg/dL) | 25 (11–46) | 25 (11–36) | 26 (13–46) | 26 (15–43) |
Creatinine (mg/dL) | 0.5 (0.3–1.0) | 0.4 (0.3–0.5) | 0.6 (0.3–0.9) | 0.6 (0.4–1.0) |
Uric acid (mg/dL) | 5.0 (1.9–8.8) | 4.3 (2.2–5.9) | 5 (1.0–8.8) | 5.5. (2.9–8.3) |
TSH (µU/mL) | 2.3 (0.8–8.0) | 2.2 (0.8–4.4) | 2.5 (0.9–8.0) | 0.8 (4.8–2.0) |
HbA1c (%) | 5.5 (4.1–11.7) | 5.4 (4.5–5.9) | 5.5. (4.1–7.0) | 4.9 (4.9–11.7) |
Fasting insulin (µU/mL) | 15.0 (1.0–85.6) | 16.8 (1.0–85.6) | 21.1 (2.8–81.5) | 23.1 (2.7–85.2) |
HOMA | 4.6 (0.0–14.2) | 3.6 (0–21.3) | 4.8 (0.6–19.5) | 5.5. (21.9–24.2) |